USP Drug Classification

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Analgesics
 
 Anesthetics
 
 Anti-Addiction/Substance Abuse Treatment Agents
 
 Antibacterials
 
 Anticonvulsants
 
 Antidementia Agents
 
 Antidepressants
 
 Antiemetics
 
 Antifungals
 
 Antigout Agents
 
 Anti-inflammatory Agents
 
 Antimigraine Agents
 
 Antimyasthenic Agents
 
 Antimycobacterials
 
 Antineoplastics
 
 Antiparasitics
 
 Antiparkinson Agents
 
 Antipsychotics
 
 Antispasticity Agents
 
 Antivirals
 
 Anxiolytics
 
 Bipolar Agents
 
 Blood Glucose Regulators
 
 Blood Products/Modifiers/Volume Expanders
 
 Cardiovascular Agents
 
 Central Nervous System Agents
 
 Dental and Oral Agents
 
 Dermatological Agents
 
 Enzyme Replacement/Modifiers
 
 Gastrointestinal Agents
 
 Genitourinary Agents
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 
 Hormonal Agents, Suppressant (Adrenal)
 
 Hormonal Agents, Suppressant (Parathyroid)
 
 Hormonal Agents, Suppressant (Pituitary)
 
 Hormonal Agents, Suppressant (Thyroid)
 
 Immunological Agents
   Angioedema (HAE) Agents
   Immune Suppressants
     Mycophenolic acid [DG:DG00739]
     Tacrolimus [DG:DG00439]
     Cyclosporine
     Tofacitinib [DG:DG00742]
     Sirolimus
     Mercaptopurine [DG:DG00683]
     Abatacept
     Anakinra
     Everolimus
     Methotrexate [DG:DG00681]
     Penicillamine [DG:DG00763]
     Pimecrolimus
     Azathioprine [DG:DG00743]
     Adalimumab
     Certolizumab pegol
     Etanercept
     Golimumab
     Infliximab
       D02598  Infliximab (USAN/INN)
   Immunizing Agents, Passive
   Immunomodulators
   Vaccines
 
 Inflammatory Bowel Disease Agents
 
 Metabolic Bone Disease Agents
 
 Ophthalmic Agents
 
 Otic Agents
 
 Respiratory Tract/Pulmonary Agents
 
 Skeletal Muscle Relaxants
 
 Sleep Disorder Agents
 
 Therapeutic Nutrients/Minerals/Electrolytes

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 21, 2016
According to the USP Medicare Model Guidelines v6.0

» Japanese version